Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)
Clinical trial NCT01030536 · COMPLETED
Trial details
- NCT number
- NCT01030536
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-15
- Primary completion
- 2013-03-04
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.